Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma
- 15 April 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (4), 499-506
- https://doi.org/10.1016/0277-5379(83)90113-x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Combination therapy for multiple myelomaCancer, 1977
- Intermittent Melphalan and Prednisolone Therapy in Plasma Cell MyelomaActa Medica Scandinavica, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972
- The Treatment of Plasma Cell MyelomaAdvances in Cancer Research, 1967
- Melphalan Therapy in MyelomatosisBMJ, 1964
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958